Dr Ella Fung 馮瑞玲
Dr Ella Sui Ling Fung obtained her Bachelor's degree in Natural Sciences from the University of Cambridge, specialising in Genetics. She then completed a European Masters in Genetics at the University of Paris Denis Diderot, where she was selected to receive training in Molecular Cell Biology at the Pasteur Institute.
Ella's main research interest is oncology, and the problem of chemotherapy and radiotherapy resistance. Her previous work focused on identifying novel molecular targets that can be used to re-sensitise cancers to treatment (1). In 2014, Fung was awarded a Croucher Scholarship to support her doctorate studies at the Oxford Institute for Radiation Oncology, under the supervision of Dr Vincenzo D'Angiolella.
- Kong B, Wang Q, Fung E, Xue K, Tsang BK. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in Gynecologic Cancers. J Biol Chem. 2014 Aug 11. pii: jbc.M114.594812. [Epub ahead of print] PubMed PMID: 25112877.
- Raducu M, Fung E, Serres S, et al. SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. EMBO J. 2016;35(13):1400-16.
Under the supervision of Dr Vincenzo D'Angiolella, Fung is currently pursuing doctorate studies at the Oxford Institute for Radiation Oncology.
- Scholarship in 2014 at the University of Oxford
PhD Student of Oxford Institute for Radiation Oncology at University of Oxford